FindTrial
Sign In

Clinical Study on the Efficacy of an Indigenous Drug Formulation in the Management of Fissure-in-Ano (Parikartika)

Studies of Indigenous Drugs Formulation in the Management of Parikartika (Fissure-in-Ano) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108931
Enrollment
60
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K600- Acute anal fissure

Interventions

None listed

Sponsors

Chandra Shekhar Singh Ayurved Chikitsalaya evam Shodh Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of fissure with controlled cases of diabetes mellitus and hypertension. The study included patients suffering from haemorrhoids and fistula in ano. Female patient with pregnancy also included.

Exclusion criteria

Exclusion criteria: Patients suffering from malignancy of any organ or ano-rectum. Positive cases of HIV, VDRL, Hepatitis-B, Tuberculosis.

Design outcomes

Primary

MeasureTime frame
Primary Outcome Measure: Reduction in pain score (VAS scale) Complete healing of fissure (epithelialization of ulcer)Timepoint: 18 Months—

Secondary

MeasureTime frame
Reduction in bleeding episodes (graded scale) Relief in burning sensation and itching (subjective scoring) Improvement in bowel habits (frequency and ease of defecation) Reduction in anal sphincter spasm (clinical assessment) Time required for complete healing of fissure Recurrence of symptoms during follow-upTimepoint: 1 Year 6 Months—

Countries

India

Contacts

Public ContactProf Dr Chhayakanta Dash

Chandra Shekhar Singh Ayurvedic Sansthan

dr.ashishpal67423@gmail.com8550022535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026